NCT05003076View on ClinicalTrials.gov

Brain Function and EEG

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
HealthyMood
Interventions
DRUG

Methamphetamine

Participants will be given 20 mg of Methamphetamine.

DRUG

Placebo

Participants will be given a placebo capsule that will only contain lactose.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER